Reuters logo
BRIEF-Thrombogenics cash and investments at end of March EUR 73.3 mln
May 11, 2017 / 4:03 PM / 4 months ago

BRIEF-Thrombogenics cash and investments at end of March EUR 73.3 mln

May 11 (Reuters) - THROMBOGENICS NV

* CASH AND INVESTMENTS WERE EUR 73.3 MILLION AS OF END OF MARCH 2017, COMPARED WITH EUR 80.1 MILLION AT END OF DECEMBER 2016

* THR-149 IS EXPECTED TO ENTER CLINIC IN H1 2018

* THR-687 IS EXPECTED TO ENTER CLINIC AROUND END OF 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below